首页 > 最新文献

Antibiotiki i Khimioterapiya最新文献

英文 中文
[Change of Tumor Cell Multiple Drug Resistance Inhibitory Activity of Oligomycins in Complexes with Lithium and Zinc]. [寡霉素与锂、锌配合物对肿瘤细胞多重耐药抑制活性的影响]。
Q4 Medicine Pub Date : 2015-01-01
M V Bibikova, A N Danilenko, A V Katlinsky, A F Korystova, L N Kublik, M Kh Levitman, V V Shaposhnikova, Yu N Korystov

Oligomycins and their complexes with lithium and zinc were shown to be less active vs. cyclosporin A in inhibition of transport proteins responsible for multiple drug resistance of lymphoid leukosis P388VR cells, while certain oligomycin complexes were tens or hundreds times more active than cyclosporin A by inhibition of transport proteins in another type of tumor cells, i.e. human larynx cancer Hep-2, that makes possible the use of the oligomycins complexes with lithium and zinc for inhibition of multiple drug resistance of certain tumor types.

与环孢素A相比,寡霉素及其与锂和锌的复合物在抑制淋巴性白血病P388VR细胞多重耐药的转运蛋白方面的活性较低,而某些寡霉素复合物在抑制另一种肿瘤细胞(即人喉癌Hep-2)中的转运蛋白方面的活性比环孢素A高数十倍或数百倍。这使得使用锂和锌的寡霉素复合物来抑制某些肿瘤类型的多重耐药成为可能。
{"title":"[Change of Tumor Cell Multiple Drug Resistance Inhibitory Activity of Oligomycins in Complexes with Lithium and Zinc].","authors":"M V Bibikova,&nbsp;A N Danilenko,&nbsp;A V Katlinsky,&nbsp;A F Korystova,&nbsp;L N Kublik,&nbsp;M Kh Levitman,&nbsp;V V Shaposhnikova,&nbsp;Yu N Korystov","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Oligomycins and their complexes with lithium and zinc were shown to be less active vs. cyclosporin A in inhibition of transport proteins responsible for multiple drug resistance of lymphoid leukosis P388VR cells, while certain oligomycin complexes were tens or hundreds times more active than cyclosporin A by inhibition of transport proteins in another type of tumor cells, i.e. human larynx cancer Hep-2, that makes possible the use of the oligomycins complexes with lithium and zinc for inhibition of multiple drug resistance of certain tumor types.</p>","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"60 11-12","pages":"9-14"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34355936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Antitumor Activity of Polysaccharides from Ganoderma lucidum Mycelium: in vivo Comparative Study]. [灵芝菌丝体多糖抗肿瘤活性的体内比较研究]。
Q4 Medicine Pub Date : 2015-01-01
L M Krasnopolskaya, M S Yarina, A V Avtonomova, A I Usov, E B Isakova, V M Bukchman

Fractions of water soluble and alkali soluble polysaccharides, as well as fucogalactan, a water soluble polysaccharide, and xylomannan, an alkali soluble polysaccharide, were isolated from the Ganoderma lucidum submerged mycelium. When administered orally, the polysaccharides showed antitumor activity in vivo on murine models of solid tumors. Xylomannan and fucogalactan showed the highest antitumor activity. Sensitivity to xylomannan was more pronounced in adenocarcinoma Ca755 as compared to the T-cell lymphocytic leukemia P388. The antitumor activity of the water soluble polysaccharides total fractions from the mycelium and fruiting bodies of the G. lucidum strain was almost identical. The maximum antitumor effect of the mycelium water soluble polysaccharides total fraction was observed with the use of the daily dose of 2 mg/kg.

从灵芝浸没菌丝体中分离出水溶性多糖和碱溶性多糖,以及水溶性多糖岩藻半乳聚糖和碱溶性多糖木甘露聚糖。经口服给药后,多糖对小鼠实体瘤模型显示出抗肿瘤活性。木甘露聚糖和岩藻半乳聚糖的抗肿瘤活性最高。与t淋巴细胞白血病P388相比,腺癌Ca755对木甘露聚糖的敏感性更为明显。该菌株菌丝体和子实体水溶性多糖总组分的抗肿瘤活性几乎相同。当日剂量为2 mg/kg时,菌丝水溶性多糖总组分的抗肿瘤作用最大。
{"title":"[Antitumor Activity of Polysaccharides from Ganoderma lucidum Mycelium: in vivo Comparative Study].","authors":"L M Krasnopolskaya,&nbsp;M S Yarina,&nbsp;A V Avtonomova,&nbsp;A I Usov,&nbsp;E B Isakova,&nbsp;V M Bukchman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Fractions of water soluble and alkali soluble polysaccharides, as well as fucogalactan, a water soluble polysaccharide, and xylomannan, an alkali soluble polysaccharide, were isolated from the Ganoderma lucidum submerged mycelium. When administered orally, the polysaccharides showed antitumor activity in vivo on murine models of solid tumors. Xylomannan and fucogalactan showed the highest antitumor activity. Sensitivity to xylomannan was more pronounced in adenocarcinoma Ca755 as compared to the T-cell lymphocytic leukemia P388. The antitumor activity of the water soluble polysaccharides total fractions from the mycelium and fruiting bodies of the G. lucidum strain was almost identical. The maximum antitumor effect of the mycelium water soluble polysaccharides total fraction was observed with the use of the daily dose of 2 mg/kg.</p>","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"60 11-12","pages":"29-34"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34355939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Optimization of Antibiotic Prophylaxis in Minor Gynecologic Operations]. [妇科小手术抗生素预防优化]。
Q4 Medicine Pub Date : 2015-01-01
M S Selikhova, S V Vdovin, M V Mikhailovskaya

The aim of the study was to estimate the efficacy of various variants of antibiotic prophylaxis of infectious complications in female patients after histeroscopy. 109 patients were examined. The patients were hospitalized for planned historoscopy. 55 of them were treated prophylactically to prevent infectious complications with a broad spectrum antibiotic administered intravenously 30 min prior to the operation. A course antimicrobial therapy during the postoperative period was applied to 54 females. The results of the trial showed that single administration of an antimicrobial provided high level prevention of infectious complications, whereas the use of course antimicrobial therapy during the postoperative period was of no advantage by the efficacy.

本研究的目的是评估不同类型的抗生素预防女性患者在组织学检查后感染并发症的疗效。109例患者接受了检查。患者住院接受计划的病史检查。其中55例采用预防性治疗,在手术前30分钟静脉给予广谱抗生素以预防感染并发症。对54例女性患者进行术后1个疗程的抗菌治疗。试验结果表明,单次使用抗菌药物可以有效预防感染并发症,而在术后期间使用抗菌药物治疗则没有疗效优势。
{"title":"[Optimization of Antibiotic Prophylaxis in Minor Gynecologic Operations].","authors":"M S Selikhova,&nbsp;S V Vdovin,&nbsp;M V Mikhailovskaya","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The aim of the study was to estimate the efficacy of various variants of antibiotic prophylaxis of infectious complications in female patients after histeroscopy. 109 patients were examined. The patients were hospitalized for planned historoscopy. 55 of them were treated prophylactically to prevent infectious complications with a broad spectrum antibiotic administered intravenously 30 min prior to the operation. A course antimicrobial therapy during the postoperative period was applied to 54 females. The results of the trial showed that single administration of an antimicrobial provided high level prevention of infectious complications, whereas the use of course antimicrobial therapy during the postoperative period was of no advantage by the efficacy.</p>","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"60 11-12","pages":"39-42"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34367845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Metaanalytic Approach to Evaluate Clinical Effectiveness of Infusion Succinnate-Containing Remaxol in Liver Pathologies of Diverse Genesis]. [荟萃分析方法评价输注含琥珀酸利马索治疗多种病因肝脏病变的临床疗效]。
Q4 Medicine Pub Date : 2015-01-01
N K Mazina, P V Mazin

Metaanalysis was applied to the published data on the randomized clinical trials of Remaxol in the treatment of various diseases associated with the liver injury: chronic hepatitis B and C, severe ethanol intoxication, drug-induced pathologies due to tuberculosis chemotherapy, leptospirosis, psoriasis, tumor polychemotherapy. The database included information on 2250 patients. The total number of the patients of the control group (n = 1099) were treated according to the routine schemes (active placebo) and that of the main group (n = 1151) were additionally treated with Remaxol. Combination of the frequency characteristics of the positive outcomes (% of elimination of the main clinical symptoms and complications) in the patients of the reference groups allowed to estimate the general clinical efficacy of Remaxol, that was equal to 1.75 by the outcome frequency characteristics. The odds ratio of the positive outcomes equaled 5.3 [1.8; 17.0] and the number of the patients needed to treat (NPNT) equaled 8 [6; 14]. Therefore, the infusion Remaxol hepatoprotector based on succinic acid was shown to have statistically and clinically significant therapeutic efficacy in pharmacologic correction of the liver pathologies of diverse genesis.

荟萃分析已发表的瑞美索治疗多种肝损伤相关疾病的随机临床试验数据:慢性乙型肝炎和丙型肝炎、严重乙醇中毒、结核病化疗引起的药物性病理、钩端螺旋体病、银屑病、肿瘤多重化疗。该数据库包括2250名患者的信息。对照组患者(n = 1099)按常规方案(活性安慰剂)治疗,主组患者(n = 1151)在此基础上加用瑞美索治疗。结合参考组患者阳性结果的频率特征(主要临床症状和并发症消除的百分比),可以估计瑞美索的一般临床疗效,结果频率特征等于1.75。阳性结果的优势比为5.3 [1.8;17.0],需要治疗的患者(NPNT)为8例[6;14)。由此可见,以琥珀酸为基础的雷美索护肝剂输注对多种病因肝脏病理的药理矫正具有统计学意义和临床意义。
{"title":"[Metaanalytic Approach to Evaluate Clinical Effectiveness of Infusion Succinnate-Containing Remaxol in Liver Pathologies of Diverse Genesis].","authors":"N K Mazina,&nbsp;P V Mazin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Metaanalysis was applied to the published data on the randomized clinical trials of Remaxol in the treatment of various diseases associated with the liver injury: chronic hepatitis B and C, severe ethanol intoxication, drug-induced pathologies due to tuberculosis chemotherapy, leptospirosis, psoriasis, tumor polychemotherapy. The database included information on 2250 patients. The total number of the patients of the control group (n = 1099) were treated according to the routine schemes (active placebo) and that of the main group (n = 1151) were additionally treated with Remaxol. Combination of the frequency characteristics of the positive outcomes (% of elimination of the main clinical symptoms and complications) in the patients of the reference groups allowed to estimate the general clinical efficacy of Remaxol, that was equal to 1.75 by the outcome frequency characteristics. The odds ratio of the positive outcomes equaled 5.3 [1.8; 17.0] and the number of the patients needed to treat (NPNT) equaled 8 [6; 14]. Therefore, the infusion Remaxol hepatoprotector based on succinic acid was shown to have statistically and clinically significant therapeutic efficacy in pharmacologic correction of the liver pathologies of diverse genesis.</p>","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"60 11-12","pages":"43-9"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34367846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Determination of Microbial Susceptibility to Sulfanilamides by Electrooptic Analysis]. 电光分析法测定微生物对磺胺类药物的敏感性
Q4 Medicine Pub Date : 2015-01-01
O I Guliy, V D Bunin, O S Larionova, E G Potemkina, O V Ignatov

The effect of sulfanilamides (soluble streptocid as an example) on changing of the electrophysical properties (EP) of microbial cells of Escherichia coli XL-1, BL-Ril, Pseudomonasputida C-11 and BA-11 was studied. It was shown that significant changes in the orientation spectra (OS) of the cell suspensions incubated at various concentrations of the sulfanilamide resulted in changing of the electrooptic (EO) signal of the cell suspension at the first five frequencies of the orientation electric field (10-1000 Hz) with the use of soluble streptocid in a concentration of 0.3 mcg/ml. The dynamics of the drug effect on the microbial cells demonstrated a decrease of the EO signal value 5 minutes after the exposure by -59% vs. the control (the cells not exposed to the drug). During the following exposure the EO signal value practically did not change (within 5%). The changes of the OS of the cell suspensions exposed to soluble streptocid significantly differed for the susceptible and resistant strains. Determination of the activity of sulfanilamides by electrooptic analysis of microbial cell suspensions was considered possible. Changing of the microbial suspencion OS under the effect of sulfanilamides can be used as a test on the microbial cell susceptibility to drugs.

研究了磺胺类药物(以可溶性链球菌为例)对大肠杆菌XL-1、BL-Ril、假单胞菌C-11和BA-11等微生物细胞电物理性质(EP)的影响。结果表明,当可溶性链球菌酸浓度为0.3 mcg/ml时,不同浓度磺胺培养的细胞悬液的取向光谱(OS)发生显著变化,导致细胞悬液在取向电场的前5个频率(10-1000 Hz)的电光信号发生变化。药物作用于微生物细胞的动力学表明,与对照组(未暴露于药物的细胞)相比,暴露5分钟后EO信号值下降了-59%。在接下来的曝光中,EO信号值几乎没有变化(在5%以内)。可溶性链球菌毒素对敏感株和耐药株细胞悬液OS的影响有显著差异。利用微生物细胞悬浮液的电光分析测定磺胺类药物的活性被认为是可行的。磺胺类药物作用下微生物混悬液OS的变化可作为微生物细胞对药物敏感性的检测指标。
{"title":"[Determination of Microbial Susceptibility to Sulfanilamides by Electrooptic Analysis].","authors":"O I Guliy,&nbsp;V D Bunin,&nbsp;O S Larionova,&nbsp;E G Potemkina,&nbsp;O V Ignatov","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The effect of sulfanilamides (soluble streptocid as an example) on changing of the electrophysical properties (EP) of microbial cells of Escherichia coli XL-1, BL-Ril, Pseudomonasputida C-11 and BA-11 was studied. It was shown that significant changes in the orientation spectra (OS) of the cell suspensions incubated at various concentrations of the sulfanilamide resulted in changing of the electrooptic (EO) signal of the cell suspension at the first five frequencies of the orientation electric field (10-1000 Hz) with the use of soluble streptocid in a concentration of 0.3 mcg/ml. The dynamics of the drug effect on the microbial cells demonstrated a decrease of the EO signal value 5 minutes after the exposure by -59% vs. the control (the cells not exposed to the drug). During the following exposure the EO signal value practically did not change (within 5%). The changes of the OS of the cell suspensions exposed to soluble streptocid significantly differed for the susceptible and resistant strains. Determination of the activity of sulfanilamides by electrooptic analysis of microbial cell suspensions was considered possible. Changing of the microbial suspencion OS under the effect of sulfanilamides can be used as a test on the microbial cell susceptibility to drugs.</p>","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"60 3-4","pages":"14-9"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34043127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Irumamicin Produced by Streptomyces roseoflavus INA-1278]. [玫瑰黄链霉菌INA-1278产Irumamicin]。
Q4 Medicine Pub Date : 2015-01-01
O A Lapchinskaya, G S Katrukha, L P Terekhova, E G Gladkikh, V V Kulyaeva, V V Pogozheva, G I Orlova, A S Trenin, G B Fedorova

The strain Streptomyces roseoflavus INA-1278 is described as a new irumamicin producer. Irumamicin 1278 is different by the antifungal activity from irumamicin produced by the world-known strain Streptomyces subflavus subsp. Irumaensis subps. nov. AM-3603.

摘要玫瑰黄链霉菌INA-1278是一种新的干扰素生产菌株。Irumamicin 1278的抗真菌活性与世界上已知的菌株Streptomyces subflavus subsp产生的Irumamicin不同。Irumaensis subps。11月是- 3603。
{"title":"[Irumamicin Produced by Streptomyces roseoflavus INA-1278].","authors":"O A Lapchinskaya,&nbsp;G S Katrukha,&nbsp;L P Terekhova,&nbsp;E G Gladkikh,&nbsp;V V Kulyaeva,&nbsp;V V Pogozheva,&nbsp;G I Orlova,&nbsp;A S Trenin,&nbsp;G B Fedorova","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The strain Streptomyces roseoflavus INA-1278 is described as a new irumamicin producer. Irumamicin 1278 is different by the antifungal activity from irumamicin produced by the world-known strain Streptomyces subflavus subsp. Irumaensis subps. nov. AM-3603.</p>","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"60 9-10","pages":"3-6"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34451738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Discovery of Genetic Markers of Resistance to β-Lactams in Gramnegative Microorganisms by PCR Diagnosis]. PCR诊断革兰氏阴性微生物β-内酰胺耐药遗传标记的发现
Q4 Medicine Pub Date : 2015-01-01
E S Lisitsina, T V Chernenkaya, E N Ilyina, I V Lazareva, V A Ageevets, S V Sidorenko

Fifteen specimens of the hemoculture and 89 specimens of the broncho-alveolar lavage were used in the study. Monocultures of gramnegative bacteria resistant to cefotaxime, cefepime, imipenem and meropenem were isolated from the specimens. The PCR method with detection of the results in the real time regimen (PCR test-system Litekh) provided detection of the beta-lactamase genes: bla(CTX-M-like) (72/104, 69.2%), bla(NDM) (6/104, 5.8%), bla(VIM) (49/104, 47.1%) and bla(OXA48-like) (59/104, 56.7%). There was identified correlation between the phenotype of resistance of Acinetobacter spp., Pseudomonas aeruginosa, Klebsiella pneumoniae and Escherichia coli to cefotaxime and carbopenems and detection of the bla(CTX-M-like) and bla(NDM) genes. At the same time, up to 70% of the K. pneumoniae isolates from the biological specimes positive with respect to the presence of the carbapenase bla(VIM) and bla(OXA48-like) genes demonstrated their phenotypic susceptibility to carbopenems. The results of the study confirmed the prognostic value of the genetic diagnosis for improvement of the routine bacteriological investigations.

血液培养标本15例,支气管肺泡灌洗标本89例。从标本中分离出对头孢噻肟、头孢吡肟、亚胺培南和美罗培南耐药的革兰氏阴性菌。实时检测结果的PCR检测方法(PCR检测系统Litekh)可检测出β -内酰胺酶基因:bla(ctx - m样)(72/104,69.2%)、bla(NDM)(6/104, 5.8%)、bla(VIM)(49/104, 47.1%)和bla(oxa48样)(59/104,56.7%)。不动杆菌、铜绿假单胞菌、肺炎克雷伯菌和大肠埃希菌对头孢噻肟和碳青霉烯类耐药表型与bla(ctx - m样)和bla(NDM)基因检测结果存在相关性。同时,从生物标本中分离出的肺炎克伯菌中,高达70%的碳青霉烯酶bla(VIM)和bla(oxa48样)基因呈阳性,表现出对碳青霉烯类的表型易感性。本研究结果证实了遗传诊断对改善常规细菌学检查的预后价值。
{"title":"[Discovery of Genetic Markers of Resistance to β-Lactams in Gramnegative Microorganisms by PCR Diagnosis].","authors":"E S Lisitsina,&nbsp;T V Chernenkaya,&nbsp;E N Ilyina,&nbsp;I V Lazareva,&nbsp;V A Ageevets,&nbsp;S V Sidorenko","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Fifteen specimens of the hemoculture and 89 specimens of the broncho-alveolar lavage were used in the study. Monocultures of gramnegative bacteria resistant to cefotaxime, cefepime, imipenem and meropenem were isolated from the specimens. The PCR method with detection of the results in the real time regimen (PCR test-system Litekh) provided detection of the beta-lactamase genes: bla(CTX-M-like) (72/104, 69.2%), bla(NDM) (6/104, 5.8%), bla(VIM) (49/104, 47.1%) and bla(OXA48-like) (59/104, 56.7%). There was identified correlation between the phenotype of resistance of Acinetobacter spp., Pseudomonas aeruginosa, Klebsiella pneumoniae and Escherichia coli to cefotaxime and carbopenems and detection of the bla(CTX-M-like) and bla(NDM) genes. At the same time, up to 70% of the K. pneumoniae isolates from the biological specimes positive with respect to the presence of the carbapenase bla(VIM) and bla(OXA48-like) genes demonstrated their phenotypic susceptibility to carbopenems. The results of the study confirmed the prognostic value of the genetic diagnosis for improvement of the routine bacteriological investigations.</p>","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"60 9-10","pages":"17-22"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34451741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Antimicrobial Activity of Substances Produced by Trichoderma citrinoviride Strain VKPM F-1228: Optimization of Cultivation and Assessment of Spectrum of Individual Peptaibols]. [柠檬酸木霉VKPM F-1228菌株的抑菌活性:培养优化及单个肽谱评价]。
Q4 Medicine Pub Date : 2015-01-01
V S Sadykova, A V Kurakov, V A Korshun, E A Rogozhin, T I Gromovykh, A E Kuvarina, A A Baranova

The Trichoderma citrinoviride VKPM F-1228 strain produces a complex of peptide-based antibiotics with antibacterial and antimycotic action. Synthesis of peptaibols is closely related to the conidiogenesis in the culture. The optimal procedure of the strain cultivation for production of peptaibols is stationary growing for 14 days at a temperature of 28 degrees C and pH 7.5 followed by formation of a dense mycelium film on the modified Saburo medium containing 30 gr/l of glucose and 12.5 gr/l of peptone. Eight individual peptaibols were extracted. The spectrum of their activity was estimated with the use of opportunistic bacteria and micromycetes as well as pathogenic clinical aspergilli. Compounds 9, 13, 14, 15 and 16 were shown active against opportunistic fungi and bacteria including methicillin resistant S. aureus, whereas compounds 9, 13 and 14 in addition showed antimycotic activity against clinical aspergilli.

柠檬酸木霉VKPM F-1228菌株产生具有抗菌和抗真菌作用的肽基抗生素复合物。多糖的合成与培养过程中的分生机制密切相关。该菌株生产肽的最佳培养工艺是在温度28℃、pH 7.5的条件下稳定生长14天,然后在含有30克/升葡萄糖和12.5克/升蛋白胨的改良Saburo培养基上形成致密的菌丝膜。提取了8个单独的肽。利用机会性细菌和微菌以及临床致病性曲霉对其活性谱进行了估计。化合物9、13、14、15和16对机会性真菌和细菌(包括耐甲氧西林金黄色葡萄球菌)有抑制作用,而化合物9、13和14对临床曲霉也有抑制作用。
{"title":"[Antimicrobial Activity of Substances Produced by Trichoderma citrinoviride Strain VKPM F-1228: Optimization of Cultivation and Assessment of Spectrum of Individual Peptaibols].","authors":"V S Sadykova,&nbsp;A V Kurakov,&nbsp;V A Korshun,&nbsp;E A Rogozhin,&nbsp;T I Gromovykh,&nbsp;A E Kuvarina,&nbsp;A A Baranova","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The Trichoderma citrinoviride VKPM F-1228 strain produces a complex of peptide-based antibiotics with antibacterial and antimycotic action. Synthesis of peptaibols is closely related to the conidiogenesis in the culture. The optimal procedure of the strain cultivation for production of peptaibols is stationary growing for 14 days at a temperature of 28 degrees C and pH 7.5 followed by formation of a dense mycelium film on the modified Saburo medium containing 30 gr/l of glucose and 12.5 gr/l of peptone. Eight individual peptaibols were extracted. The spectrum of their activity was estimated with the use of opportunistic bacteria and micromycetes as well as pathogenic clinical aspergilli. Compounds 9, 13, 14, 15 and 16 were shown active against opportunistic fungi and bacteria including methicillin resistant S. aureus, whereas compounds 9, 13 and 14 in addition showed antimycotic activity against clinical aspergilli.</p>","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"60 11-12","pages":"3-8"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34355935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Antibiotic Resistance of MRSA in the Russian Federation]. [MRSA在俄罗斯联邦的抗生素耐药性]。
Q4 Medicine Pub Date : 2015-01-01
V V Gostev, O S Kalinogorskaya, L N Popenko, T V Chernenkaya, Z S Naumenko, T M Voroshilova, Yu A Zakharova, O E Khokhlova, A N Kruglov, M G Ershova, I V Molchanova, S V Sidorenko

The results of the multicentre trial on estimation of MRSA antibiotic susceptibility to 17 antibiotics are presented. 474 nonrepeting isolates of MRSA (mecA+), collected in 2011-2014 in 10 cities of the Russian Federation were used in the trial. The antibiotic susceptibility was determined by the method of serial microdilutions in broth with estimation of the MICs in accordance with the international standards CLSI 2014 and EUCAST 2014. The highest levels of the MRSA resistance were stated against ciprofloxacin--92%(MIC50 32 mcg/ml), gentamicin--85% (MIC50 128 mcg/ml), erythromycin--54% (MIC50 32-mcg/ml) and clindainycin - 45% (MIC50 0.03 mcg/ml), as well as against rifampicin--38% (MIC50 0.06 mcg/ml). The frequency of MRSA isolated at the vancomycin dose of 2 mcg/ml equaled 26%. No correlation of the decrease in susceptibility to vancomycin and rifampicin was observed. In 5% of MRSA isolated from infected surgical wounds in patients with bone infection or sepsis, there was observed a decrease in the susceptibility to ceftarolin (MIC 2-4 mcg/ml). Co-trimoxasole, fusidic acid (MIC50 0.06 mcg/ml) and mupirocin (MIC50 0.5 mcg/ml) showed high antibacterial activity, 93-98% of the isolates being susceptible to the drugs. No resistance to linezolid and tigecycline was detected. By the associate resistance spectrum, most of the MRSA isolates were characterized by resistance to drugs of 3-7 groups (56%). The phenotypes with simultaneous resistance to drugs of 8-10 groups amounted to 6%. As a whole, 70 variants of associate resistance combinations were detected.

介绍了MRSA对17种抗生素敏感性的多中心试验结果。试验使用2011-2014年在俄罗斯联邦10个城市收集的474株非重复MRSA (mecA+)分离株。采用肉汤连续微稀释法测定药敏度,mic值按照国际标准CLSI 2014和EUCAST 2014进行估算。MRSA耐药水平最高的是环丙沙星92%(MIC50 32微克/毫升),庆大霉素85% (MIC50 128微克/毫升),红霉素54% (MIC50 32微克/毫升),克林霉素45% (MIC50 0.03微克/毫升),以及利福平38% (MIC50 0.06微克/毫升)。万古霉素剂量为2 mcg/ml时,MRSA的分离率为26%。对万古霉素和利福平的敏感性降低没有相关性。在骨感染或败血症患者手术伤口感染中分离出的5%的MRSA中,观察到对头孢他林(MIC 2-4微克/毫升)的敏感性降低。复方新沙索、福西地酸(MIC50为0.06 mcg/ml)和莫匹罗星(MIC50为0.5 mcg/ml)具有较高的抗菌活性,93 ~ 98%的菌株对该药敏感。对利奈唑胺和替加环素均无耐药。联合耐药谱显示,大多数MRSA分离株均有3 ~ 7组耐药(56%)。8 ~ 10组同时耐药表型占6%。总共检测到70个相关耐药组合变异。
{"title":"[Antibiotic Resistance of MRSA in the Russian Federation].","authors":"V V Gostev,&nbsp;O S Kalinogorskaya,&nbsp;L N Popenko,&nbsp;T V Chernenkaya,&nbsp;Z S Naumenko,&nbsp;T M Voroshilova,&nbsp;Yu A Zakharova,&nbsp;O E Khokhlova,&nbsp;A N Kruglov,&nbsp;M G Ershova,&nbsp;I V Molchanova,&nbsp;S V Sidorenko","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The results of the multicentre trial on estimation of MRSA antibiotic susceptibility to 17 antibiotics are presented. 474 nonrepeting isolates of MRSA (mecA+), collected in 2011-2014 in 10 cities of the Russian Federation were used in the trial. The antibiotic susceptibility was determined by the method of serial microdilutions in broth with estimation of the MICs in accordance with the international standards CLSI 2014 and EUCAST 2014. The highest levels of the MRSA resistance were stated against ciprofloxacin--92%(MIC50 32 mcg/ml), gentamicin--85% (MIC50 128 mcg/ml), erythromycin--54% (MIC50 32-mcg/ml) and clindainycin - 45% (MIC50 0.03 mcg/ml), as well as against rifampicin--38% (MIC50 0.06 mcg/ml). The frequency of MRSA isolated at the vancomycin dose of 2 mcg/ml equaled 26%. No correlation of the decrease in susceptibility to vancomycin and rifampicin was observed. In 5% of MRSA isolated from infected surgical wounds in patients with bone infection or sepsis, there was observed a decrease in the susceptibility to ceftarolin (MIC 2-4 mcg/ml). Co-trimoxasole, fusidic acid (MIC50 0.06 mcg/ml) and mupirocin (MIC50 0.5 mcg/ml) showed high antibacterial activity, 93-98% of the isolates being susceptible to the drugs. No resistance to linezolid and tigecycline was detected. By the associate resistance spectrum, most of the MRSA isolates were characterized by resistance to drugs of 3-7 groups (56%). The phenotypes with simultaneous resistance to drugs of 8-10 groups amounted to 6%. As a whole, 70 variants of associate resistance combinations were detected.</p>","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"60 1-2","pages":"3-9"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34283242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[PK/PD Modeling as a Tool for Predicting Bacterial Resistance to Antibiotics: Alternative Analyses of Experimental Data]. [PK/PD模型作为预测细菌对抗生素耐药性的工具:实验数据的替代分析]。
Q4 Medicine Pub Date : 2015-01-01
M V Golikova, E N Strukova, Y A Portnoy, A A Firsov

Postexposure number of mutants (NM) is a conventional endpoint in bacterial resistance studies using in vitro dynamic models that simulate antibiotic pharmacokinetics. To compare NM with a recently introduced integral parameter AUBC(M), the area under the time course of resistance mutants, the enrichment of resistant Staphylococcus aureus was studied in vitro by simulation of mono(daptomycin, doxycycline) and combined treatments (daptomycin + rifampicin, rifampicin + linezolid). Differences in the time courses of resistant S. aureus could be reflected by AUBC(M) but not N(M). Moreover, unlike AUBC(M), N(M) did not reflect the pronounced differences in the time courses of S. aureus mutants resistant to 2x, 4x, 8x and 16xMIC of doxycycline and rifampicin. The findings suggested that AUBC(M) was a more appropriate endpoint of the amplification of resistant mutants than N(M).

暴露后突变体数量(NM)是利用体外动态模型模拟抗生素药代动力学进行细菌耐药性研究的传统终点。为了比较NM与最近引入的耐药突变体时间进程下的积分参数AUBC(M),通过模拟单药(达托霉素、强力霉素)和联合治疗(达托霉素+利福平、利福平+利奈唑胺),研究了耐药金黄色葡萄球菌在体外的富集情况。耐药金黄色葡萄球菌时间进程的差异可以用AUBC(M)来反映,但不能用N(M)来反映。此外,与AUBC(M)不同,N(M)并没有反映金黄色葡萄球菌突变体对强力霉素和利福平的2倍、4倍、8倍和16倍mic耐药时间的显著差异。结果表明,AUBC(M)比N(M)更适合作为耐药突变体扩增的终点。
{"title":"[PK/PD Modeling as a Tool for Predicting Bacterial Resistance to Antibiotics: Alternative Analyses of Experimental Data].","authors":"M V Golikova,&nbsp;E N Strukova,&nbsp;Y A Portnoy,&nbsp;A A Firsov","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Postexposure number of mutants (NM) is a conventional endpoint in bacterial resistance studies using in vitro dynamic models that simulate antibiotic pharmacokinetics. To compare NM with a recently introduced integral parameter AUBC(M), the area under the time course of resistance mutants, the enrichment of resistant Staphylococcus aureus was studied in vitro by simulation of mono(daptomycin, doxycycline) and combined treatments (daptomycin + rifampicin, rifampicin + linezolid). Differences in the time courses of resistant S. aureus could be reflected by AUBC(M) but not N(M). Moreover, unlike AUBC(M), N(M) did not reflect the pronounced differences in the time courses of S. aureus mutants resistant to 2x, 4x, 8x and 16xMIC of doxycycline and rifampicin. The findings suggested that AUBC(M) was a more appropriate endpoint of the amplification of resistant mutants than N(M).</p>","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"60 9-10","pages":"12-6"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34451740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Antibiotiki i Khimioterapiya
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1